Pulmonary arterial hypertension trials in Serbia

5 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.

• Phase 2Taking people
  Study of TX000045 in Participants With Pulmonary Hypertension Due to Interstitial Lung Disease

  Where

  Belgrade, Kamenitz, Niš

  Age

  18 years to 80 years

  People

  25 worldwide

  Run by

  Tectonic Operating Company, Inc.

  See details and how to joinNCT07473700
• Phase 3Taking people
  Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

  Where

  Belgrade, Kamenitz, Kragujevac

  Age

  18 years and over

  People

  344 worldwide

  Run by

  Insmed Incorporated

  See details and how to joinNCT07179380 · EU 2025-521558-40-00
• Phase 3Taking people
  Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)

  Where

  Belgrade

  Age

  18 years to 75 years

  People

  330 worldwide

  Run by

  Gossamer Bio USA, Inc.

  See details and how to joinNCT06274801 · EU 2023-506334-75-00
• Phase 3Enrolling by invitation
  A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension

  Where

  Belgrade, Kamenitz

  Age

  18 years and over

  People

  1,000 worldwide

  Run by

  United Therapeutics

  See details and how to joinNCT03683186 · EU 2023-509305-68-00
• Phase 1/2Taking people
  A Study to Learn About the Treatment LTP001 in Healthy Participants (Part A) and in Participants With PAH (Part B)

  Where

  Belgrade, Kamenitz, Niš

  Age

  18 years to 100 years

  People

  232 worldwide

  Run by

  Novartis Pharmaceuticals

  See details and how to joinNCT06649110